302 related articles for article (PubMed ID: 2846074)
1. Purification and partial characterization of membrane-associated type II (cGMP-activatable) cyclic nucleotide phosphodiesterase from rabbit brain.
Whalin ME; Strada SJ; Thompson WJ
Biochim Biophys Acta; 1988 Oct; 972(1):79-94. PubMed ID: 2846074
[TBL] [Abstract][Full Text] [Related]
2. Characterization and selective inhibition of cyclic nucleotide phosphodiesterase isozymes in canine tracheal smooth muscle.
Torphy TJ; Cieslinski LB
Mol Pharmacol; 1990 Feb; 37(2):206-14. PubMed ID: 2154670
[TBL] [Abstract][Full Text] [Related]
3. Purification and properties of the cGMP-inhibited cAMP phosphodiesterase from bovine aortic smooth muscle.
Rascón A; Lindgren S; Stavenow L; Belfrage P; Andersson KE; Manganiello VC; Degerman E
Biochim Biophys Acta; 1992 Mar; 1134(2):149-56. PubMed ID: 1313303
[TBL] [Abstract][Full Text] [Related]
4. Characterization of cyclic nucleotide phosphodiesterases from cultured bovine aortic endothelial cells.
Lugnier C; Schini VB
Biochem Pharmacol; 1990 Jan; 39(1):75-84. PubMed ID: 2153383
[TBL] [Abstract][Full Text] [Related]
5. Isolation and characterization of bovine cardiac muscle cGMP-inhibited phosphodiesterase: a receptor for new cardiotonic drugs.
Harrison SA; Reifsnyder DH; Gallis B; Cadd GG; Beavo JA
Mol Pharmacol; 1986 May; 29(5):506-14. PubMed ID: 3010079
[TBL] [Abstract][Full Text] [Related]
6. Purification and characterization of a cyclic GMP-stimulated cyclic nucleotide phosphodiesterase from bovine tissues.
Martins TJ; Mumby MC; Beavo JA
J Biol Chem; 1982 Feb; 257(4):1973-9. PubMed ID: 6276403
[TBL] [Abstract][Full Text] [Related]
7. Single-step affinity purification, partial structure and properties of human platelet cGMP inhibited cAMP phosphodiesterase.
Degerman E; Moos M; Rascón A; Vasta V; Meacci E; Smith CJ; Lindgren S; Andersson KE; Belfrage P; Manganiello V
Biochim Biophys Acta; 1994 Apr; 1205(2):189-98. PubMed ID: 8155697
[TBL] [Abstract][Full Text] [Related]
8. Ca(2+)/calmodulin-dependent cyclic nucleotide phosphodiesterase in cGMP metabolism in rabbit parotid acinar cells.
Sairenji N; Satoh K; Sugiya H
Biomed Res; 2006 Feb; 27(1):37-44. PubMed ID: 16543664
[TBL] [Abstract][Full Text] [Related]
9. Purification and characterization of guanosine 3',5'-monophosphate-inhibited low K(m) adenosine 3',5'-monophosphate phosphodiesterase from human placental cytosolic fractions.
LeBon TR; Kasuya J; Paxton RJ; Belfrage P; Hockman S; Manganiello VC; Fujita Yamaguchi Y
Endocrinology; 1992 Jun; 130(6):3265-74. PubMed ID: 1317779
[TBL] [Abstract][Full Text] [Related]
10. The identification and characterization of two cyclic nucleotide phosphodiesterases from bovine adrenal medulla.
Sabatine JM; Coffee CJ
Arch Biochem Biophys; 1986 Aug; 249(1):95-105. PubMed ID: 3017224
[TBL] [Abstract][Full Text] [Related]
11. Purification, characterization and production of rabbit antibodies to rat liver particulate, high-affinity, cyclic AMP phosphodiesterase.
Whitson RH; Appleman MM
Biochim Biophys Acta; 1982 Feb; 714(2):279-91. PubMed ID: 6275911
[TBL] [Abstract][Full Text] [Related]
12. Characterization of a Ca2+-calmodulin-stimulated cyclic GMP phosphodiesterase from bovine brain.
Shenolikar S; Thompson WJ; Strada SJ
Biochemistry; 1985 Jan; 24(3):672-8. PubMed ID: 2986683
[TBL] [Abstract][Full Text] [Related]
13. Subcellular distribution of high-affinity type IV cyclic AMP phosphodiesterase activities in rabbit ventricular myocardium: relations to post-natal maturation.
Kithas PA; Artman M; Thompson WJ; Strada SJ
J Mol Cell Cardiol; 1989 May; 21(5):507-17. PubMed ID: 2550653
[TBL] [Abstract][Full Text] [Related]
14. Characterization of cyclic AMP phosphodiesterases in Leishmania mexicana and purification of a soluble form.
Rascón A; Viloria ME; De-Chiara L; Dubra ME
Mol Biochem Parasitol; 2000 Mar; 106(2):283-92. PubMed ID: 10699257
[TBL] [Abstract][Full Text] [Related]
15. Phosphodiesterase II, the cGMP-activatable cyclic nucleotide phosphodiesterase, regulates cyclic AMP metabolism in PC12 cells.
Whalin ME; Scammell JG; Strada SJ; Thompson WJ
Mol Pharmacol; 1991 Jun; 39(6):711-7. PubMed ID: 1646946
[TBL] [Abstract][Full Text] [Related]
16. Purification, properties and polyclonal antibodies for the particulate, low Km cAMP phosphodiesterase from bovine adipose tissue.
Degerman E; Manganiello VC; Newman AH; Rice KC; Belfrage P
Second Messengers Phosphoproteins; 1988; 12(4):171-82. PubMed ID: 2854560
[TBL] [Abstract][Full Text] [Related]
17. Purification and characterization of a human platelet cyclic nucleotide phosphodiesterase.
Grant PG; Colman RW
Biochemistry; 1984 Apr; 23(8):1801-7. PubMed ID: 6326810
[TBL] [Abstract][Full Text] [Related]
18. Subcellular distribution of high-affinity type IV cyclic AMP phosphodiesterase activity in rabbit ventricular myocardium: relations to the effects of cardiotonic drugs.
Kithas PA; Artman M; Thompson WJ; Strada SJ
Circ Res; 1988 Apr; 62(4):782-9. PubMed ID: 2832097
[TBL] [Abstract][Full Text] [Related]
19. Characterization of phosphodiesterase 4 in guinea-pig macrophages: multiple activities, association states and sensitivity to selective inhibitors.
Kelly JJ; Barnes PJ; Giembycz MA
Br J Pharmacol; 1998 May; 124(1):129-40. PubMed ID: 9630352
[TBL] [Abstract][Full Text] [Related]
20. [Cyclic AMP-specific nucleotide phosphodiesterase from the insoluble fraction of the human brain].
Kireeva NN; Bobruskin ID; Severin SE
Biokhimiia; 1995 May; 60(5):694-708. PubMed ID: 7662796
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
